Technology | Contrast Media | December 11, 2017

Sectra Offers Gadolinium Tracking Functionality in DoseTrack Software

Radiologists can now collect, store and monitor contrast injection data during MRI exams

Sectra Offers Gadolinium Tracking Functionality in DoseTrack Software

December 11, 2017 — Sectra recently announced the global introduction of gadolinium tracking in its dose monitoring solution, Sectra DoseTrack. Gadolinium is a contrast agent commonly used to enhance images during magnetic resonance imaging (MRI) exams. By systematically registering gadolinium information, healthcare providers can reduce the risk of patients experiencing negative side effects of excessively high accumulated levels of gadolinium.

Sectra showcased Sectra DoseTrack, including this functionality, during the Radiological Society of North America (RSNA) annual meeting, Nov. 26-Dec. 1, 2017 in Chicago.

Ian Judd, product manager for Sectra DoseTrack, said by entering gadolinium injection information in the software, healthcare providers can ensure relevant information is available throughout the organization either from the electronic medical record (EMR), from the dose monitoring solution or in Sectra PACS (picture archiving and communication system).

Sectra DoseTrack allows healthcare providers to monitor patient radiation exposure and ensure that the radiation doses are kept as low as reasonably achievable (ALARA) for increased patient safety. The cloud-based solution automatically collects, stores and monitors data from all connected modalities, saving time and facilitating robust analysis for dose optimization. It can be configured using local and national dose reference levels (DRLs) to allow healthcare organizations to ensure it is performing within expected thresholds.

Watch the VIDEO How Serious is MRI Gadolinium Retention in the Brain and Body?

Read the article FDA: No Harm in MRI Gadolinium Retention in the Brain

For more information: www.sectra.com

 

Related Content

According to the new market research report "Radiation Dose Management Market by Products & Services (Standalone Solutions, Integrated Solutions, Services), Modality (Computed Tomography, Nuclear Medicine), Application (Oncology, Cardiology, Orthopedic), End User (Hospitals) - Global Forecast to 2025", published by MarketsandMarkets, the radiation dose management market is projected to reach USD 422.65 million by 2025 from USD 220.22 million in 2020, at a CAGR of 13.9%.

Courtesy of MarketsandMarkets Research

News | Radiation Dose Management | August 03, 2020
August 3, 2020 — According to the new market research report "...
(a) A schematic of cycloidal computed tomography (not to scale, seen from top); by adding an array of beam stops in front of the detector, the setup is transformed into an edge-illumination x-ray phase-contrast imaging device. (b) A sinogram sampling grid for a rotation-only scheme. (c) A sinogram sampling grid for a cycloidal scheme. The grids are shown for one mask period and a subset of rotation angles; the combination of empty and filled circles shows the grids that would be achieved through fine latera

(a) A schematic of cycloidal computed tomography (not to scale, seen from top); by adding an array of beam stops in front of the detector, the setup is transformed into an edge-illumination x-ray phase-contrast imaging device. (b) A sinogram sampling grid for a rotation-only scheme. (c) A sinogram sampling grid for a cycloidal scheme. The grids are shown for one mask period and a subset of rotation angles; the combination of empty and filled circles shows the grids that would be achieved through fine lateral sampling (requiring dithering); the filled circles show the data that are sampled without dithering.

News | Computed Tomography (CT) | July 24, 2020
July 24, 2020 — A computed tomography (CT) sca
The Global Contrast Injectors Market will grow by $613.47M during 2020-2024, according to Technavio
News | Contrast Media Injectors | June 17, 2020
June 17, 2020 — Technavio has been monitoring the ...
The FDA has approved Lilly’s TAUVID (flortaucipir F 18 injection), a radioactive diagnostic agent, for PET imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease

Getty Images

News | Contrast Media | June 01, 2020
June 1, 2020 — TAUVID, a radioactive diagnostic agent, has been approved by the FDA for...
Researchers from Tokyo Metropolitan University have surveyed the amount of gadolinium found in river water in Tokyo. Gadolinium is contained in contrast agents given to patients undergoing medical magnetic resonance imaging (MRI) scans, and it has been shown in labs to become toxic when exposed to ultraviolet rays. The researchers found significantly elevated levels, particularly near water treatment plants, highlighting the need for new public policy and removal technologies as MRI become even more commonp

Samples were taken along rivers around Tokyo. Measurements of rare earth element quantities indicate a clearly elevated amount of gadolinium compared to that in natural shale. Graphics courtesy of Tokyo Metropolitan University

News | Magnetic Resonance Imaging (MRI) | May 26, 2020
May 26, 2020 — Researchers from Tokyo Metropolitan...
“Everybody cares about radiation dose, but the most sensitive to radiation are children, because they’re growing.”  —Richard Towbin, M.D., Chief of Radiology, Phoenix Children’s Hospital

“Everybody cares about radiation dose, but the most sensitive to radiation are children, because they’re growing.”
—Richard Towbin, M.D., Chief of Radiology, Phoenix Children’s Hospital

Sponsored Content | Case Study | Radiation Dose Management | April 09, 2020
Medical imaging plays an increasing role in the accurate diagnosis and treatment of numerous medical conditions.
Rising concerns over radiation overexposure teamed with a growing focus on improving the quality of patient care are two key drivers of today’s radiation dose management market. 

Rising concerns over radiation overexposure teamed with a growing focus on improving the quality of patient care are two key drivers of today’s radiation dose management market. 

Feature | Radiation Dose Management | April 02, 2020 | By Melinda Taschetta-Millane
Rising concerns over...